News

Gauteng discusses future of lay counsellors Living with AIDS # 537

The Gauteng Health Department held talks with lay HIV counsellors and other community health workers this week to discuss options of managing and incorporating them into the health system. Currently, they are employed through various non-governmental organisations and are not recognised as employees of the department.

Read More » Gauteng discusses future of lay counsellors Living with AIDS # 537
e0a4966e003d

KZN HIV-911 directory

The latest edition of the KwaZulu-Natal HIV-911 Directory of HIV-Related Services is now available. The directory contains information on 2 297 organisations actively involved in HIV, TB and STI-related prevention, treatment and support in the province. It also includes information on organisations providing socio-economic, legal and psycho-social support programmes. Service provider information is categorised by municipality and type of service offered. The database is updated on an annual basis .

Read More » KZN HIV-911 directory
8c5a3588edfe

Keeping children in school shows impact on HIV risk behaviours in Kenya

Providing free school uniforms to enable children to stay in school, in addition to exposing primary school students to the national HIV/AIDS prevention curriculum, appeared to have a greater effect on reducing risky sexual behaviours among youth and in particular girls in Western Kenya than either intervention alone, Dr Vandana Sharma reported on Wednesday at the 19th International AIDS Conference (AIDS 2012) in Washington.

Read More » Keeping children in school shows impact on HIV risk behaviours in Kenya
3d3e6bf62450

Trial signals major milestone in hunt for new TB drugs

WASHINGTON'€” A novel approach to discover the first new tuberculosis (TB) combination drug regimen cleared a major hurdle when Phase II clinical trial results found it could kill more than 99 percent of patients' TB bacteria within two weeks and could be more effective than existing treatments, according to a study published today in the Lancet. These results add to a growing body of evidence that the new regimen could reduce treatment by more than a year for some patients.

Read More » Trial signals major milestone in hunt for new TB drugs

Newsletter Subscription

Be in the know with our free weekly newsletter. We deliver a round-up of our top stories and insightful reads from across the web.

  • This field is for validation purposes and should be left unchanged.
Enable Notifications OK No thanks